Hasil Pencarian  ::  Simpan CSV :: Kembali

"Penyebaran mikroba yang resisten terhadap pengobatan merupakan tantangan kesehatan masyarakat yang menyeluruh, yang akan menurunkan efektivitas obat dan mengakibatkan tingginya angka kesakitan dan kematian serta bertambahnya biaya pengobatan. Pengawasan resistensi obat antimikrobial melalui laporan data tentang pola resistensi mikroba terhadap suatu antimikroba akan berguna untuk mencegah timbulnya resistensi. Pada studi ini akan dilaporkan tentang pola resistensi mikroba terhadap ceftriaxone dalam 4 tahun terakhir. Data yang dilaporkan ini berasal dari spesimen yang diperiksa di Laboratorium Mikrobiologi Klinik, Departemen Mikrobiologi FKUI dari tahun 2002 sampai dengan 2005. Spesies mikroba ditentukan melalui kultur dan uji identifikasi. Disc Diffussion Methods digunakan untuk uji sensitivitas ceftriaxone terhadap 14 bakteri Gram-negatif dan 7 bakteri Gram-positif. Hasilnya memperlihatkan, walaupun angka resistensi mikroba terhadap ceftriaxone meningkat dari tahun 2002 sampai 2005, tetapi secara umum masih kurang dari 50%. Angka resistensi yang rendah (< 3%) terlihat untuk Salmonella typhi, Salmonella paratyphi A, Shigella flexneri, Serratia marcescens, dan Streptococcus pneumoniae. Hasil ini dapat digunakan untuk menyusun pedoman penggunaan ceftriaxone di Indonesia.

---

AbstractThe spread of drug resistant microbes is a global public health challenge which impairs the efficacy of antimicrobial agents and causes substantial increase in morbidity and mortality rates, including healthcare-associated costs. Monitoring of antimicrobial drug resistance from documented microbial epidemiology & resistance rate is useful in preventing the emergence of resistance. This study reports on the pattern of bacterial resistance against ceftriaxone in the past 4 years. The data were obtained from specimens examined in the Clinical Microbiology Laboratory, Department of Microbiology Faculty of Medicine, University of Indonesia from 2002 to 2005. Microbial species were determined from culture and identification tests. Disc diffusion method was used for sensitivity testing of ceftriaxone to 14 Gram-negative and 7 Gram-positive bacteria. Although resistance rates were increased from 2002 to 2005, resistance rates of ceftriaxone were found to be less than 50%. Low resistance rates (< 3%) were observed for Salmonella typhi, Salmonella paratyphi A, Shigella flexneri, Serratia marcescens, and Streptococcus pneumoniae. These results could be useful in developing guidelines on the use of ceftriaxone in Indonesia. "

"This book, which is the translated version of a Swedish book, combines a general introduction of a variety of antibiotics with a more in-depth discussion of resistance. The focus on resistance in learning about antibiotics will help future scientists recognize the problem antibiotics resistance poses for medicinal and drug-related fields, and perhaps trigger more research and discoveries to fight antibiotic resistant strains. Current overviews of the topic are included, along with specific discussions on the individual mechanisms (betalactams, glycopeptides, aminoglycosides, etc) used in various antibacterial agents and explanations of how resistances to those develop. Methods for counteracting resistance development in bacteria are discussed as well."

"This book describes antibiotic resistance amongst pathogenic bacteria. It starts with an overview of the erosion of the efficacy of antibiotics by resistance and the decrease in the rate of replacement of redundant compounds. The origins of antibiotic resistance are then described. It is proposed that there is a large bacterial resistome which is a collection of all resistance genes and their precursors in both pathogenic and non-pathogenic bacteria. Ongoing resistance surveillance programs are also discussed, together with the perspective of a clinical microbiologist. The book then turns to specific themes such as the most serious area of resistance in pathogens, namely in Gram-negative organisms. The role of combinations of antibiotics in combating resistance emergence is discussed, particularly in the tuberculosis field, and then the importance of non-multiplying and persistent bacteria which are phenotypically resistant to antibiotics and prolong the duration of therapy of antibiotics which leads to poor compliance and resistance emergence. The role of anti-microbial compounds in textiles is covered, with its potential to exacerbate the spread of resistance. Then, efflux pumps are discussed. The final chapter describes the compounds which are in late stage clinical development, illustrating the paucity of the antibiotic pipeline, especially for Gram-negative bacteria."

"Latar Belakang : Meropenem, salah satu antibiotik yang paling efektif terhadap bakteri gram negatif dan bakteri gram positif, dianggap sebagai pengobatan terakhir yang paling dapat diandalkan untuk infeksi bakteri. Penyebaran yang cepat dari resistensi meropenem, terutama diantara bakteri gram negatif, merupakan masalah kesehatan yang sangat penting. Berbagai faktor diketahui berhubungan dengan kejadian resistensi meropenem terhadap bakteri gram negatif, namun penelitian yang dilakukan pada pasien infeksi intra abdomen masih terbatas. Tujuan : Mengetahui faktor-faktor yang berhubungan dengan resistensi antibiotik meropenem terhadap bakteri gram negatif pada pasien infeksi intra-abdomen di RSCM tahun 2013-2017. Metode : Penelitian desain cross sectional dengan mengambil data dari rekam medis pasien infeksi intra abdomen pada rentang waktu tahun 2013-2017 sebanyak keseluruhan populasi terjangkau. Hasil : Tidak terdapat perbedaan bermakna secara statistik dari faktor-faktor yaitu, usia, jenis kelamin, penyakit yang menyertai, riwayat antibiotik, jumlah leukosit dan jumlah albumin yang berhubungan dengan resistensi meropenem terhadap bakteri gram negatif. Kesimpulan : Usia, jenis kelamin, penyakit yang menyertai, riwayat antibiotik, jumlah leukosit dan jumlah albumin bukan merupakan faktor yang berhubungan dengan resistensi meropenem terhadap bakteri gram negatif pada pasien infeksi intra abdomen. Penelitian lebih lanjut dibutuhkan untuk mengetahui pengaruh faktor-faktor lain yang berhubungan dengan resistensi meropenem terhadap bakteri gram negatif pada pasien infeksi intra abdomen.

---

Background : Meropenem, one of the most effective antibiotics against gram-negative bacteria and gram-positive bacteria, is considered to be the most reliable last treatment for bacterial infections. The rapid spread of meropenem resistance, especially among gram negative bacteria, is a very important health problem. Various factors are known to be associated with the incidence of meropenem resistance to gram-negative bacteria, but studies conducted on patients with intra-abdominal infections are still limited.

Objectives : To determine the factors associated with meropenem resistance against gram-negative bacteria in patients with intra-abdominal infections at Cipto Mangunkusumo Hospital in the year of 2013-2017.

Methods : A cross sectional design study by taking data from medical records of intra-abdominal infection patients in the period of 2013-2017 as much as the entire affordable population.

Results : There were no statistically significant differences in factors, namely age, sex, accompanying disease, history of antibiotics, number of leucocyte and amount of albumin associated with meropenem resistance against gram-negative bacteria.

Conclusion : Age, sex, accompanying disease, history of antibiotics, number of leucocytes and amount of albumin are not factors associated with meropenem resistance against gram-negative bacteria in patients with intra-abdominal infections. Further research is needed to determine the effect of other factors related to meropenem resistance against gram-negative bacteria in patients with intra-abdominal infections. "

"Kasus TB RO menyebabkan beban pengendalian penyakit TB menjadi bertambah. Adanya penurunan angka keberhasilan pengobatan dari tahun 2010 (67,9%) menjadi 51,1% tahun 2013 dan peningkatan kasus pasien putus berobat mendorong Indonesia menerapkan pengobatan jangka pendek untuk meningkatkan angka keberhasilan pengobatan TB RO dan menurunkan kasus pasien putus berobat. Penelitian ini melihat hasil pengobatan TB RO dan faktor yang berhubungan dengan hasil pengobatan regimen pendek di Indonesia tahun 2017 menggunakan desain penelitian kohort retrospektif. Menggunakan data pasien TB RO yang tercatat dalam e-TB manager berusia ≥15 tahun yang telah menyelesaikan pengobatan regimen pendek maksimal pada bulan November 2018. Didapatkan 223 kasus dengan 46,6% sembuh, 26,5 % putus berobat, 4,9% pengobatan lengkap, 14,2 meninggal, 6,3% gagal dan 1,3% lainnya. Usia, jenis kelamin, riwayat pengobatan sebelumnya, jenis resistensi, status HIV, status diabetes mellitus dan status kavitas paru secara statistik tidak berhubungan dengan hasil pengobatan regimen pendek. Faktor yang berhubungan dengan hasil pengobatan regimen pendek ialah resisten terhadap amikasin (RR 7.4; 95% CI 4.68-17.29), ofloksasin (RR 28; 95% CI 2.8-279.5), dan kanamisin (RR 9; 95% CI 4.68-17.29), dan interval inisiasi pengobatan > 7 hari (RR 0.307; CI 0.09-0.98).

---

The case of drug-resistant tuberculosis causes the burden of controlling TB disease to increase. The decline in treatment success rates from 2010 (67.9%) to 51.1% in 2013 and an increase in cases of patients dropped out encouraged Indonesia to apply short-term treatment to increase the success rate of DR-TB treatment and reduce cases of patients dropped out. This study aims to look the results of DR-TB treatment and factors related to treatment outcomes for short regimens in Indonesia in 2017 using a retrospective cohort study design. Using data on DR-TB patients recorded in the e-TB manager aged ≥15 years who have completed treatment for the maximum short regimen in November 2018. There were 223 cases with 46.6% cured, 26.5% dropped out, 4.9% completed, 14.2 died, 6.3% failed and 1.3% others. Age, gender, previous treatment history, type of resistance, HIV status, DM status and lung cavity status were not statistically related to the results of treatment of short regimens. Factors related to the results of treatment of short regimens were resistant to amikacin (RR 7.4; 95% CI 4.68-17.29), ofloxacin (RR 28; 95% CI 2.8-279.5), kanamycin (RR 9; 95% CI 4.68-17.29), and treatment initiation interval >7 days (RR 0.307; CI 0.09-0.98)."

"Antibiotika golongan penisilin adalah antibiotika yang paling luas serta paling banyak digunakan untuk terapi pasien infeksi. Dari berbagai studi diperoleh fakta bahwa telah banyak mikroba resisten terhadap penisilin. Pemberian penisilin yang telah resisten berbahaya bagi pasien dengan penyakit infeksi, selain itu lebih lambatnya penemuan obat baru serta lebih mahalnya harga obat baru merupakan hal penting yang berhubungan dengan kejadian resistensi. Resistensi sendiri dapat berubah menurut waktu dan berbeda di setiap tempat. Penelitian ini bertujuan untuk mengetahui pola resistensi bakteri yang diisolasi dari darah di Laboratorium Mikrobiologi Klinik Fakultas Kedokteran Universitas Indonesia (LMK FKUI) terhadap beberapa antibiotik penisilin, yaitu amoksilin, sulbenisilin, amoksilin/asam klavulanat , tikarsilin dan oksasilin selama periode 2001-2006. Pada penelitian ini digunakan data isolat darah dengan bakteri positif yang diisolasi di LMK FKUI selama periode 2001-2006. Data diolah dengan menggunakan piranti lunak WHONET 5.4. Dari 791 isolat darah, didapatkan enam bakteri tersering penyebab bakteremia yaitu Staphylococcus epidermidis (25%), Acinetobacter anitratus (16%), Pseudomonas aeruginosa (13%), Klebsiella pneumoniae (8%), Staphylococcus aureus (6%), dan Salmonella Typhi (5%). Hasil uji resitensi menunjukkan kejadian resistensi bakteri terhadap amoksilin sudah tinggi pada Klebsiella pneumoniae , masih cukup rendah pada Salmonella Typhi, sedangkan keampuhannya terhadap Staphylococcus epidermidis, dan Staphylococcus aureus mulai menurun. Kejadian resistensi bakteri terhadap sulbenisilin rendah pada Staphylococcus epidermidis,Staphylococcus aureus dan Salmonella Typhi , dan sudah cukup tinggi pada Klebsiella pneumoniae. Kejadian amoksilin/asam klavulanat sudah tinggi pada Acinetobacter anitratus dan Pseudomonas aeruginosa dan masih cukup rendah pada Klebsiella pneumoniae, Salmonella Typhi, Staphylococcus epidermidis, dan Staphylococcus aureus. Kejadian resistensi bakteri terhadap tikarsilin sudah tinggi pada Acinetobacter anitratus, Pseudomonas aeruginosa dan Klebsiella pneumoniae dan masih cukup rendah pada, Salmonella Typhi,dan Staphylococcus epidermidis. Kejadian resistensi Staphylococcus aureus terhadap oksasilin masih cukup rendah, sedangkan keampuhan oksasilin terhadap Staphylococcus epidermidis mulai menurun.

---

The group of penicillins antibiotics is the widest and the most used antibiotics for infection patient therapy. From several studies, there is a fact that many microbes have resistence to penicillins. The giving of penicillin that has resisted to a patient who gets an infection may be perilous. Besides that, the slower invention of new medicines and the more expensive their prices are important factors related to the resistance. The resistance itself may change in every second of time and would be different in some places. The research which was conducted in Clinical Microbiology Laboratory FMUI aims to know the pattern of the resistance of bacteria which is isolated from blood toward several kinds of penicillin; they are amoxicillin, sulbenicillin, amoxicillin/ clauvalanic acid, ticarcillin, and oxacillin between 2001-2006. The data was processed using WHONET 5.4 software. From 174 isolat bloods, there are six kinds of bacteria that often cause bacterimia; they are Staphylococcus epidermidis (25%), Acinetobacter anitratus (16%), Pseudomonas aeroginosa (13%), Klebsiella pneumoniae (8%), Staphylococcus aureus (6%), and Salmonella typhi (5%). The result of resistance test shows that the frequency of bacteria’s resistance toward amoxillin has been high in Klebsiella pneumoniae and still low in Salmonella Typhi, on the other hand, the effectiveness of amoxicillin toward Staphylococcus epidermidis and Staphylococcus aerus is getting decreased. The frequency of bacteria’s resistance toward sulbenicillin still low in Staphylococcus epidermidis, Staphylococcus aerus and Salmonella Typhi and has been high in Klebsiella pneumoniae. The frequency of bacteria’s resistance toward amoxicillin/ clavulaic acid has been high in Acinetobacter anitratus and Pseudomonas aeruginosa and still low in Klebsiella pneumoniae, Salmonella Typhi, Staphylococcus epidermidis, and Staphylococcus aureus. The frequency of bacteria’s resistance toward ticarcillin has been high in Acinetobacter anitratus, Pseudomonas aeuginosa and Klebsiella pneumoniae and still low in Salmonella Typhi and Staphylococcus epidermidis. The frequency of Staphylococcus aerus is still low. On the other hand, the effectiveness of oxacillin toward Staphylococcus epidermidis is getting decreased."

"Penyebaran mikroba resisten terhadap pengobatan merupakan tantangan kesehatan masyarakat yang menyeluruh yang akan menurunkan efektivitas obst dsn mengakibatkantingginya angka kesakitan dan kematian serta bertambahnya biaya pengobatan"

"Interactions of yeasts, moulds, and antifungal agents : how to detect resistance covers the available antifungal agents, how to perform in vitro testing and how those results should be interpreted for the most common fungal pathogens."

"Peningkatan persentase resistensi antimikroba (AMR) yang cukup tinggi di Indonesia disebabkan oleh penggunaan antimikroba yang tidak tepat, terutama dalam pelayanan kesehatan. Salah satu cara untuk mengatasi AMR adalah dengan mengoptimalkan penggunaan antibiotik. Maka dari itu, diperlukan evaluasi penggunaan antibiotik di fasilitas pelayanan kesehatan untuk memastikan optimalisasi penggunaan antibiotik tersebut. Pada penelitian ini, dilakukan evaluasi penggunaan antibiotik secara kuantitatif dengan metode ATC/DDD di Puskesmas Kelurahan Kampung Melayu pada periode 2021. Pengumpulan data dilakukan secara retrospektif dengan menggunakan data sekunder berupa Laporan Pemakaian dan Lembar Permintaan Obat (LPLPO) periode 2021 milik Puskesmas Kelurahan Kampung Melayu yang diperoleh dari arsip LPLPO di Puskesmas Kecamatan Jatinegara. Data diolah menggunakan Microsoft Excel 2022 berdasarkan jenis antibiotik, rute pemberian, dan klasifikasi ATC yang telah ditetapkan oleh WHO. Setelah itu dihitung total kekuatan antibiotik yang digunakan, serta analisis kuantitatif menggunakan metode DDD/1000 penduduk/hari. Berdasarkan persentase pemakaian dan nilai DDD/1000 penduduk/hari, lima antibiotik yang paling banyak digunakan yaitu Amoksisilin (52,78%; 0,4284 DDD), Azitromisin (18,86%; 0,1531 DDD), Siprofloksasin (8,08%; 0,0655 DDD), Sefadroksil (5,85%; 0,0475 DDD), dan Doksisiklin (5,09%; 0,0413 DDD). Jumlah total penggunaan antibiotik di Puskesmas Kelurahan Kampung Melayu selama tahun 2021 yaitu sebesar 6228,80 DDD dan 0,8116 DDD/1000 penduduk/hari.

---

The increase in the percentage of antimicrobial resistance (AMR) in Indonesia is relatively high and primarily caused by inappropriate use of antimicrobials, especially in healthcare services. One way to address AMR is by optimizing the use of antibiotics. Therefore, it is necessary to evaluate the use of antibiotics in healthcare facilities to ensure their optimal use. This study quantitatively evaluated antibiotic usage using the ATC/DDD method at the Puskesmas Kelurahan Kampung Melayu during the period 2021. Data collection was done retrospectively using secondary data, specifically the Drug Use and Request Form (LPLPO) for 2021, obtained from the archives of the Puskesmas Kecamatan Jatinegara. The data were processed using Microsoft Excel 2022, categorized by antibiotic type, administration route, and WHO-established ATC classification. Subsequently, the total antibiotic strength used was calculated, and quantitative analysis was performed using the DDD/1000 inhabitants/day method. Based on the percentage of usage and DDD/1000 inhabitants/day values, the five most commonly used antibiotics were Amoxicillin (52.78%; 0.4284 DDD), Azithromycin (18.86%; 0.1531 DDD), Ciprofloxacin (8.08%; 0.0655 DDD), Cefadroxil (5.85%; 0.0475 DDD), and Doxycycline (5.09%; 0.0413 DDD). The total amount of antibiotics used at the Puskesmas Kelurahan Kampung Melayu in 2021 was 6228.80 DDD and 0.8116 DDD/1000 inhabitants/day."